The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-08
DOI
10.1038/s41375-018-0227-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
- (2018) Gerrit J. Schuurhuis et al. BLOOD
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
- (2017) Hamid Bolouri et al. NATURE MEDICINE
- inv(16) and NPM1mut AMLs engraft human cytokine knock-in mice
- (2016) J. M. Ellegast et al. BLOOD
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Comprehensive mutational profiling of core binding factor acute myeloid leukemia
- (2016) N. Duployez et al. BLOOD
- Prognostic significance of FLT3-ITD in pediatric acute myeloid leukemia: a meta-analysis of cohort studies
- (2016) Xiaoli Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
- (2015) C. Michel Zwaan et al. JOURNAL OF CLINICAL ONCOLOGY
- Childhood and adolescent cancer statistics, 2014
- (2014) Elizabeth Ward et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
- (2014) Alan S. Gamis et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- (2012) U. Creutzig et al. BLOOD
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia
- (2011) Todd M. Cooper et al. CANCER
- High Proportion of Leukemic Stem Cells at Diagnosis Is Correlated with Unfavorable Prognosis in Childhood Acute Myeloid Leukemia
- (2011) Kai-Erik Witte et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
- (2010) Andrew J. Gentles JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
- (2010) Christine J. Harrison et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- (2009) B. V. Balgobind et al. BLOOD
- Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data–Based Meta-Analysis of the German Acute Myeloid Leukemia Intergroup
- (2009) Jürgen Krauter et al. JOURNAL OF CLINICAL ONCOLOGY
- Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
- (2008) I H I M Hollink et al. LEUKEMIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started